Prajwal Rajappa, Director, Pediatric Precision Oncology at the Cleveland Clinic, shared a post on LinkedIn:
“I’m thrilled to have recently joined the Cleveland Clinic as the Director of Pediatric Precision Oncology.
In this role, I will lead efforts across the enterprise to integrate precision oncology approaches—including molecular diagnostics and next-generation sequencing—into the standard of care for pediatric and young adult patients with cancer.
As a physician-scientist specializing in Immuno-oncology, my laboratory is based in the Center for Immunotherapy and Precision Immuno-oncology, where we will also continue our work to advance cellular immunotherapies that may improve outcomes for children, adolescents, and young adults facing cancer. Our goal is to bridge cutting-edge research with personalized clinical care.
I am excited to collaborate with Timothy Chan, Rabi Hanna, Justin Lathia and the incredible team of clinicians, scientists, and staff at Cleveland Clinic while contributing to innovations that I hope will make a meaningful impact for our patients and their families!”